Metirosine
From Wikipedia, the free encyclopedia
Metirosine
|
|
Systematic (IUPAC) name | |
2-amino-3-(4-hydroxyphenyl)-2-methyl-propanoic acid | |
Identifiers | |
CAS number | 672-87-7 |
ATC code | C02KB01 |
PubChem | 10123 |
Chemical data | |
Formula | C10H13N1O3 |
Mol. weight | 195.215 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 3.4 - 3.7 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
[edit] Mechanism of action
Metirosine is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis.
[edit] Clinical Use
Metirosine is used in the treatment of phaeochromocytoma. It is contra-indicated for the treatment of essential hypertension.
Antihypertensives (C02) and diuretics (C03) edit | ||
---|---|---|
Antiadrenergic agents (including alpha): |
Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine, Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine |
|
Vasodilators: |
Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine |
|
Other antihypertensives: | ||
Low ceiling diuretics: |
Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine |
|
High ceiling diuretics: | ||
Potassium-sparing diuretics: |